Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.
Abstract | OBJECTIVE: MATERIALS AND METHODS: RESULTS: Expression levels of NF-κB1, NF-κB2, and Rel genes were found to be deregulated. CONCLUSION: These results could be accepted as specific gene traces to radiation-induced leukemia or as potential candidates for new diagnostic biomarker studies. Larger experiments and non-exposed control malignant cell populations are needed to clarify these suggestions.
|
Authors | Hakan Savlı, Ramis Ufuk Akkoyunlu, Naci Çine, Daniil F Gluzman, Michael P Zavelevich, Lilia M Sklyarenko, Stella V Koval, Deniz Sünnetçi |
Journal | Turkish journal of haematology : official journal of Turkish Society of Haematology
(Turk J Haematol)
Vol. 33
Issue 1
Pg. 8-14
(Mar 05 2016)
ISSN: 1308-5263 [Electronic] Turkey |
PMID | 25912249
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- NF-kappa B
- NF-kappa B p50 Subunit
- NF-kappa B p52 Subunit
- Transcription Factor RelA
|
Topics |
- Adult
- Aged
- Chernobyl Nuclear Accident
- Female
- Genes, rel
- Humans
- Leukemia, Radiation-Induced
(epidemiology, etiology, genetics)
- Lymphoma
(epidemiology, etiology, genetics, metabolism)
- Male
- Middle Aged
- Myelodysplastic Syndromes
(epidemiology, etiology, genetics, metabolism)
- NF-kappa B
(biosynthesis, genetics)
- NF-kappa B p50 Subunit
(biosynthesis, genetics)
- NF-kappa B p52 Subunit
(biosynthesis, genetics)
- Neoplasms, Radiation-Induced
(epidemiology, etiology, genetics, metabolism)
- Real-Time Polymerase Chain Reaction
- Transcription Factor RelA
(biosynthesis, genetics)
- Ukraine
(epidemiology)
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|